Search results
Pfizer, Flagship to focus on obesity drugs under $100M collaboration - Boston Business Journal
The Business Journals· 22 hours agoAlmost a year after Cambridge’s Flagship Pioneering and Pfizer Inc. announced a partnership to...
Novo’s Blockbuster Obesity Drug Wegovy Under Fire in Denmark
Bloomberg· 3 hours agoA Danish drug oversight panel advised doctors to restrict prescriptions of Novo Nordisk A/S’s...
Flagship taps startup to hunt for obesity drugs that might interest Pfizer
BioPharma Dive via Yahoo Finance· 1 day agoThe venture firm will work with ProFound Therapeutics to “rapidly surface” protein drug candidates...
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 23 hours agoBlue Cross Blue Shield of Michigan is dropping coverage of popular weight loss drugs, citing...
Weight Loss Drugs Like Wegovy and Ozempic May Change Sense of Taste
Prevention via AOL· 3 hours agoWeight loss drugs like Wegovy and Ozempic may change sense of taste and how the brain reacts to...
New KFF Analysis Finds Costly GLP-1 Drugs ( includes Wegovy and Ozempic) are Rarely Covered for...
Sierra Sun Times· 2 hours agoAffordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data. Wegovy ...
For Black Women, Accessing Weight-Loss Drugs Is a Difficult Journey
PopSugar· 1 hour agoFor many Black women facing or in the obesity index, it can often feel like there's no way out when...
Anti-obesity drugs will be 2024’s defining trend
Clinical Trials Arena via Yahoo Finance· 1 day agoGlobalData’s latest update notes the impact of the growing anti-obesity market, personalised medicines, real-world evidence, and cell and gene therapies.
Is Ozempic an Obesity Drug, or an Everything Drug?
The Atlantic· 2 days agoThere’s no such thing as a miracle cure for weight loss, but the latest obesity drugs seem to come pretty close. People who take Ozempic or other weekly...
Michigan’s largest insurer to drop weight-loss drug coverage
Chicago Tribune· 22 hours agoWeight-loss drugs from Novo Nordisk A/S and Eli Lilly & Co. will lose coverage under many plans run...